This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grufferman, S., Gillman, M.W., Pasternak, L.R., Peterson, C.L. & Young, W.G. Cancer 46, 2116–2122 (1980).
Van der Mey, A.G.L., Maaswinkel-Mooy, P.D., Cornelisse, C.J., Schmidt, P.H. & van de Kamp, J.J.P. Lancet 2, 1291–1294 (1989).
Heutink, P. et al. Hum. Mol. Genet. 1, 7–10 (1992).
Baysal, B.E. et al. Hum. Genet. 104, 219–225 (1999).
Mariman, E.C.M., van Beersum, S.E.C., Cremers, C.W.R.J., Struycken, P.M. & Ropers, H.H. Hum. Genet. 95, 56–62 (1995).
Niemann, S., Steinberger, D. & Müller, U. Neurogenetics 2, 167–170 (1999).
Baysal, B.E. et al. Science 287, 848–851 (2000).
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S. & Kita, K. Cytogenet. Cell Genet. 79, 132–138 (1997).
Acknowledgements
We thank members of the family for participation; J. Zimmer and A. Köhler for transforming and culturing of patient cells; and K. Altland for help with densitometry. Patient II.6 was operated on by H. Glanz. This work was supported by the Bundesministerium für Forschung und Bildung (Förderkennzeichen: 01GI9999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niemann, S., Müller, U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26, 268–270 (2000). https://doi.org/10.1038/81551
Issue Date:
DOI: https://doi.org/10.1038/81551
This article is cited by
-
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement
Nature Reviews Endocrinology (2024)
-
Complex II subunit SDHD is critical for cell growth and metabolism, which can be partially restored with a synthetic ubiquinone analog
BMC Molecular and Cell Biology (2021)
-
Oncometabolites in renal cancer
Nature Reviews Nephrology (2020)
-
Glutamine reliance in cell metabolism
Experimental & Molecular Medicine (2020)
-
Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations
BMC Cancer (2019)